Viatris Inc.
VTRS Healthcare Drug Manufacturers Specialty & Generic
Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.
Follow VTRS
Viatris Inc. (VTRS) Gross margin
Viatris Inc.'s gross margin over the twelve months to 30 June 2026 was 34.8%, down 0.2 percentage points from fiscal 2025 (35.1%). Over the past ten years it has ranged from 31.2% (fiscal 2021) to 44.7% (fiscal 2015); the current reading is higher than 45% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 53.9% and below the Healthcare sector median of 53.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 35.1% | (3.09) |
| FY2024 | 38.2% | (3.59) |
| FY2023 | 41.7% | 1.79 |
| FY2022 | 40.0% | 8.78 |
| FY2021 | 31.2% | (0.61) |
| FY2020 | 31.8% | (2.11) |
| FY2019 | 33.9% | (1.11) |
| FY2018 | 35.0% | (5.17) |
| FY2017 | 40.2% | (2.23) |
| FY2016 | 42.4% | (2.31) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 38.8% | 5.87 |
| Mar 2026 | 32.9% | 1.91 |
| Dec 2025 | 31.0% | (5.49) |
| Sep 2025 | 36.5% | (0.73) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.9% |
| UTHR United Therapeutics Corporation compare | 86.1% |
| ZTS Zoetis Inc. compare | 71.7% |
| TAK Takeda Pharmaceutical Co. compare | 65.9% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 52.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 50.0% |
| VTRS Viatris Inc. | 34.8% |
| Drug Manufacturers Specialty & Generic industry median | 53.9% |
| Healthcare sector median | 53.5% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on VTRS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement